Targacept to Present at the 15th Annual BIO CEO & Investor Conference

[at noodls] – Winston-Salem, North Carolina February 04, 2013 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Dr. Stephen A. Hill, … more

View todays social media effects on TRGT

View the latest stocks trending across Twitter. Click to view dashboard

See who Targacept is hiring next, click here to view